# A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)

> **NCT00480662** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 60 (actual)

## Conditions studied

- Paget's Disease of Bone

## Interventions

- **DRUG:** alendronate

## Key facts

- **NCT ID:** NCT00480662
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2002-10
- **Final completion:** 2002-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480662, "A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00480662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*